Cited by 79Regulation of Appetite and ObesityNeuropeptides and Animal PhysiologyBlood Pressure and Hypertension Studies

Endogenous Melanocortin System Activity Contributes to the Elevated Arterial Pressure in Spontaneously Hypertensive Rats

Open access
da Silva, Alexandre A., do Carmo, Jussara M., Kanyicska, Bela, Dubinion, John, Brandon, Elizabeth, Hall, John E.·2008·Hypertension

Abstract

Previous studies suggest that activation of the CNS melanocortin system reduces appetite while increasing sympathetic activity and arterial pressure. The present study tested whether endogenous activity of the CNS melanocortin 3/4 receptors (MC3/4-R) contributes to elevated arterial pressure in the spontaneously hypertensive rat (SHR), a model of hypertension with increased sympathetic activity. A cannula was placed in the lateral ventricle of male SHR and Wistar (WKY) rats for chronic intracerebroventricular (ICV) infusions (0.5 μL/h). Mean arterial pressure (MAP) and heart rate (HR) were recorded 24 hour/d using telemetry. After 5-day control period, rats were infused with MC3/4-R antagonist (SHU-9119, 1 nmol/h-ICV) for 12 days, followed by 5-day posttreatment period. MC3/4-R antagonism increased food intake in SHR by 90% and in WKY by 125%, resulting in marked weight gain, insulin resistance, and hyperleptinemia in SHR and WKY. Despite weight gain, MC3/4-R antagonism reduced HR in SHR and WKY (≈40 bpm), while lowering MAP to a greater extent in SHR (−22±4 mm Hg) than WKY (−4±3 mm Hg). SHU9119 treatment failed to cause further reductions in MAP during chronic adrenergic blockade with propranolol and terazosin. These results suggest that endogenous activity of the CNS melanocortin system contributes to the maintenance of adrenergic tone and elevated arterial pressure in SHR even though mRNA levels for POMC and MC4R in the mediobasal hypothalamus were not increased compared to WKY. These results also support the hypothesis that weight gain does not raise arterial pressure in the absence of a functional MC3/4-R.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.107.100636

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MC4R antagonism in spontaneously hypertensive rats caused hyperphagia, rapid increases in adiposity, insulin resistance and a reduction in blood pressure.

    “Conversely, MC4R antagonism in SHRs caused hyperphagia, rapid increases in adiposity, insulin resistance and a reduction in BP197.”
  • The blood pressure-reducing effects of MC4R blockade are enhanced in spontaneously hypertensive rats and other models of hypertension associated with increased sympathetic nerve activity.

    “The BP-reducing effects of MC4R blockade are enhanced in SHRs and other models of hypertension that are associated with increased SNA197.”
  • MC4R antagonism decreased blood pressure by more than 25 mmHg in spontaneously hypertensive rats, which have increased sympathetic nerve activity but are not obese and do not have high leptin levels.

    “MC4R antagonism also decreased BP by >25 mmHg in SHRs, which have increased SNA but are not obese and do not have high levels of leptin197.”
  • Blockade of CNS MC4R in rodents causes voracious feeding, rapid weight gain, and reduces rather than increases BP.

    “Conversely, blockade of CNS MC4R in rodents causes voracious feeding, rapid weight gain, and reduces rather than increases BP123.”
  • In experimental models of hypertension with high sympathetic nervous system activity, blockade of the melanocortin-4 receptor reduces blood pressure despite causing marked hyperphagia and obesity.

    “In experimental models of hypertension with high SNS activity, blockade of the melanocortin-4 receptor (MC4R) reduces BP despite causing marked hyperphagia and obesity.”

    From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [42]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 25 · Cited by 79

Authors
da Silva, A. A., do Carmo, J. M., Kanyicska, B., Dubinion, J., Brandon, E., & Hall, J. E.
Affiliations
  • From the Department of Physiology and Biophysics (A.A.d.S., J.M.d.C., J.D., E.B., J.E.H.), the Department of Anatomy (B.K.), and the Center for Excellence in Cardiovascular-Renal Research (A.A.d.S., J.M.d.C., J.D., E.B., J.E.H.), University of Mississippi Medical Center, Jackson.
  • University of Mississippi Medical Center (US)
Venue
Hypertension
Published
2008-04
Volume
51
Issue
4
Pages
884-890
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2020018784
Cited by
79
References
25
Citations by year
2026: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 8 · 2013: 5 · 2012: 3
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Heart Association
  • National Heart, Lung, and Blood Institute (P01-HL-51971, P01HL051971)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
melanocortin 3/4 receptor, spontaneously hypertensive rats, arterial pressure, intracerebroventricular infusion, dietary intake, weight gain, insulin resistance, leptin, heart rate, adrenergic tone, propranolol, terazosin, proopiomelanocortin, melanocortin-4 receptor, mediobasal hypothalamus, sympathetic activity
MeSH terms
Adrenergic alpha-Antagonists, Animals, Antihypertensive Agents, Blood Pressure, Eating, Female, Heart Rate, Hypertension, Renal, Hypothalamus, Male, Melanocyte-Stimulating Hormones, Neuropeptide Y, Prazosin, Pro-Opiomelanocortin, Propranolol, Rats, Inbred SHR, Rats, Inbred WKY, RNA, Messenger, Sympathetic Nervous System, Receptor, Melanocortin, Type 3, Receptor, Melanocortin, Type 4, Rats, Melanocortins, Agouti-Related Protein, Receptors, Leptin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review